Articles by James Calloway
UiPath Stock Slips After AI-Driven Earnings Surge; ARR Growth in Focus
UiPath shares retreated to $12.18 after surging 12% on strong Q1 results and first-ever GAAP profitability, as Wall Street weighs agentic AI potential against rising competition.
Idaho Power Seeks Approval for Two Gas Plants to Address Capacity Gaps
Idaho Power seeks state approval for two new gas plants to address projected capacity deficits of 236 MW in 2029 and 352 MW in 2030, with no immediate rate hike proposed.
Victoria's Secret Surges to Record, Then Retreats on Valuation Concerns
Victoria's Secret shares hit a record high after a strong quarter and raised profit outlook, but cooled premarket as analysts see limited upside after the rally.
White House Mandates 30-Day Federal Review for Advanced AI Systems
President Trump's executive order mandates a voluntary 30-day federal cybersecurity review for advanced AI models from OpenAI, Google, and Anthropic before wider release, potentially delaying product launches.
HPE Rallies on AI Demand, Outlook Boost; Analysts Raise Targets
HPE jumped 19.5% after raising its fiscal 2026 revenue growth outlook to 29-33% on record Q2 sales. Analysts boosted price targets as AI-driven server and networking demand surged.
GameStop Posts Record Profit, Unveils $2B Buyback Amid eBay Pursuit
GameStop posted record Q1 net income of $389.6 million, driven by collectibles, and announced a $2 billion buyback. Shares jumped 7.4% after hours.
Ulta Beauty Shares Surge After Strong Quarter, Profit Forecast Raised
Ulta Beauty raised its full-year profit forecast after beating quarterly earnings and comparable sales estimates, sending shares up 7% in extended trading.
Palo Alto Networks Surges on AI Security Demand, Lifts 2026 Forecast
Palo Alto Networks shares soared 7.4% in extended trading after raising its 2026 revenue and profit guidance, driven by a 31% revenue jump to $3.0 billion and robust AI security demand.
Abivax Stock Tumbles 44% Despite Positive Ulcerative Colitis Trial Results
Abivax shares fell 44% as strong Phase 3 results for obefazimod in ulcerative colitis were overshadowed by malignancy cases, fueling investor worries about regulatory approval.
Grab Stock Flat as Investors Eye Digital Banking Expansion
Grab Holdings shares barely moved as Q1 results impressed with 24% revenue growth, but unchanged full-year guidance and risks tied to its Superbank consolidation kept investors on edge.
Shake Shack Stock Plunges 10% on Outlook Cut Amid Demand Woes
Shake Shack shares dropped 10.3% after slashing Q2 and 2026 outlooks, citing macroeconomic uncertainty and competition. Revenue and margin forecasts were cut.